IGC Pharma, Inc. Quarterly Other Assets, Current in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
IGC Pharma, Inc. quarterly Other Assets, Current history and growth rate from Q1 2012 to Q3 2024.
  • IGC Pharma, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $198K, a 38.5% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $198K +$55K +38.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $240K +$47K +24.4% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $115K -$147K -56.1% Mar 31, 2024 10-Q 2024-11-12
Q4 2023 $124K -$29K -19% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $143K $0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $193K -$58K -23.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $262K -$74K -22% Mar 31, 2023 10-K 2024-06-24
Q4 2022 $153K +$4K +2.69% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $143K -$85K -37.3% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $251K +$44K +21.3% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $336K +$140K +71.4% Mar 31, 2022 10-K 2023-07-07
Q4 2021 $149K +$57K +62% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $228K -$21K -8.43% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $207K +$72K +53.3% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $196K -$27K -12.1% Mar 31, 2021 10-K 2022-06-23
Q4 2020 $92K +$10K +12.2% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $249K +$164K +193% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 $135K +$43K +46.7% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 $223K +$205K +1139% Mar 31, 2020 10-K 2021-06-14
Q4 2019 $82K -$150K -64.7% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $85K -$147K -63.4% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $92K +$76.9K +509% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $18K +$7K +63.6% Mar 31, 2019 10-K 2020-07-13
Q4 2018 $232K +$226K +4106% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 $232K +$227K +4603% Sep 30, 2018 10-Q 2018-10-16
Q2 2018 $15.1K +$9.75K +182% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $11K -$144K -92.9% Mar 31, 2018 10-K 2019-06-14
Q4 2017 $5.52K +$516 +10.3% Dec 31, 2017 10-Q 2018-02-20
Q3 2017 $4.93K -$12.1K -71.1% Sep 30, 2017 10-Q 2017-11-17
Q2 2017 $5.36K -$20.5K -79.3% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 $155K +$138K +804% Mar 31, 2017 10-K 2018-06-21
Q4 2016 $5K -$41.9K -89.3% Dec 31, 2016 10-Q 2017-02-21
Q3 2016 $17.1K -$31.4K -64.7% Sep 30, 2016 10-Q 2016-11-21
Q2 2016 $25.9K -$23K -47.1% Jun 30, 2016 10-Q 2016-08-16
Q1 2016 $17.2K -$32.4K -65.3% Mar 31, 2016 10-K 2017-07-14
Q4 2015 $46.9K +$10.4K +28.5% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 $48.4K +$11.8K +32.3% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $48.9K +$10.8K +28.5% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $49.5K +$13.8K +38.8% Mar 31, 2015 10-K 2016-07-14
Q4 2014 $36.5K -$116K -76.1% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 $36.6K +$7.12K +24.1% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $38.1K +$13.4K +54.6% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $35.7K +$18.8K +112% Mar 31, 2014 10-K 2015-07-14
Q4 2013 $152K -$58.1K -27.6% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 $29.5K -$182K -86.1% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $24.6K -$162K -86.8% Jun 30, 2013 10-Q 2013-08-16
Q1 2013 $16.8K -$180K -91.4% Mar 31, 2013 10-K 2014-07-15
Q4 2012 $211K Dec 31, 2012 10-Q 2013-02-13
Q3 2012 $212K Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $186K Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 $197K Mar 31, 2012 10-K/A 2014-07-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.